Market Overview

Merck Reports Q2 Earnings Beat


Merck & Co (NYSE: MRK) reported second-quarter earnings of $1.30 per share, which beat the analyst consensus estimate of $1.16 by 12.07%. This is a 22.64% increase over earnings of $1.06 per share from the same period last year.

The company reported quarterly sales of $11.76 billion, which beat the analyst consensus estimate of $10.96 billion by 7.30%. This is a 12.37% increase over sales of $10.465 billion the same period last year.

See Also: Merck's Keytruda Gets A Double Dose Of Positive News

"Our science-led strategy and execution across our key growth pillars have driven another quarter of accelerating revenue growth with strength across our global portfolio," said Ken Frazier, CEO of Merck. "We remain confident that our innovative products and significant pipeline opportunities will continue to deliver strong results and provide sustainable value to patients and shareholders."

Merck shares were trading up 3.03% at $84.99 in Tuesday’s pre-market session. The stock has a 52-week high of $87.07 and a 52-week low of $62.38.

Posted-In: Earnings News


Related Articles (MRK)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at